RNA Targeting Small Molecules Therapeutics Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $21.95 Billion
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Present And Forecasted Size Of The RNA Targeting Small Molecules Therapeutics Market?
In the latest years, the market size for therapeutics of small molecules targeting RNA has experienced significant expansion. It’s projected to expand from $6.1 billion in 2024 to $7.83 billion in 2025, displaying a compound annual growth rate (CAGR) of 28.3%. Factors contributing to this growth during the historic period include advancements in drug discovery and development, an increased array of RNA-related diseases, both government and private sector funding, interest from the pharmaceutical industry, and success stories involving RNA therapeutics.
The market for RNA targeting small molecules therapeutics is projected to witness significant gains in the coming years, rising to “$21.95 billion by 2029 at an annual compound growth rate (CAGR) of 29.4%. The predicted growth for this period can be ascribed to the upsurge in precision medicine and personalized therapies, increase in RNA biomarker identification, expansion of RNA target spectrum, larger funding and investments, and application in rare diseases. Key trends for the forecast period encompass improvements in screening technologies, domination of antisense oligonucleotides, small molecule RNA binders, RNA therapeutics in neurological disorders, and gene editing with CRISPR-Cas9.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12253&type=smp
Which Key Factors Are Fueling Growth In The RNA Targeting Small Molecules Therapeutics Market?
The rise in cancer occurrences is projected to fuel the expansion of the RNA-targeting small molecule therapeutics market. Cancer is a classification of diseases that can manifest in practically any organ or tissue as irregular cells grow beyond control, exceed their normal limits, and either metastasize to other organs or invade nearby body structures. RNA-targeting small molecules, designed and studied specifically to target RNA molecules implicated in cancer, are used in cancer treatment. For example, research published by the American Cancer Society, a US-based health organization, in January 2022, forecasts around 609,360 cancer fatalities and 1.9 million new cancer cases in the US in 2022. This translates to roughly 1,670 deaths every day. As a result, the burgeoning number of cancer diagnoses is spurring the growth of the RNA-targeting small molecule therapeutics market.
How Is The RNA Targeting Small Molecules Therapeutics Market Categorized Across Applications And Types?
The rna targeting small molecules therapeutics market covered in this report is segmented –
1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings
2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications
3) By Application: Drug Discovery, Oncology Research, Disease Identification
4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By mRNA (Messenger Ribonucleic Acid) Translation Modulators: Small Molecule Inhibitors, Enhancers Of Translation
2) By RNA (Ribonucleic Acid) Splicing Modification: Splicing Modulators, Antisense Oligonucleotides
3) By Direct RNA (Ribonucleic Acid) Targeting: RNA-Binding Small Molecules, RNA Aptamers
4) By Other Offerings: RNA Interference (RNAi) Therapeutics, Small Molecule Activators Of RNA Stability
How Are Market Trends Influencing Competition In The RNA Targeting Small Molecules Therapeutics Market?
A significant trend in the RNA-targeting small molecule therapeutics market is the formation of strategic alliances. Key players in this market are forming partnerships to foster relationships that lead to the development of groundbreaking products. Otsuka Pharmaceutical Co. Ltd., a pharmaceutical manufacturer from Japan, partnered with xFOREST Therapeutics Co. Ltd, another Japan-based company known for their drug discovery platforms in June 2022. The collaboration allows xFOREST to provide Otsuka with its Forest technology, advancing systemic small-molecule drug research centred on RNA structures. Later, in April 2024, Ipsen, a biopharmaceutical company from France, collaborated with Skyhawk Therapeutics, a clinical-stage biotechnology firm from the US specializing in RNA-targeting small molecule therapeutics. The objective of this collaboration was the development of RNA-targeting small molecule drugs to treat rare neurological diseases and to utilize various data sets to discover and develop small molecules capable of modulating RNA.
Who Are The Primary Market Leaders In The RNA Targeting Small Molecules Therapeutics Market?
Major companies operating in the RNA targeting small molecules therapeutics market include F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The RNA Targeting Small Molecules Therapeutics Market?
North America was the largest region in the RNA targeting small molecules therapeutics market in 2024. The regions covered in the RNA targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12253&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
